A central strategy for Natumin Pharma

Through competence and experience a number of unique products have been marketed throughout the world. Our product development and our research are based on three important factors.

1. Network of expertise
Natumin Pharma works with several international independent scientists and specialists that contributes with expertise on both product development but also on clinical documentation.

2. Product documentation
A large part of Natumin Pharmas budget is spent on clinical trials and studies related to product effect and safety. The studies and trials are performed within the international parameters of “Good Clinical Practice”.

3. Regulatory
An other important factor for Natumin Pharma is the regulatory function that is a necessity in order for our products to meet
authority regulations in different countries